uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Cardiac impact of inhaled therapy in the largest randomised placebo-controlled trial in COPD history: have we reached the SUMMIT?
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences, Respiratory Medicine and Allergology.
2016 (English)In: ERJ open research, Vol. 2, no 2, 00055-2016Article in journal (Refereed) Published
Abstract [en]

SUMMIT supports the efficiency and cardiovascular safety of LABA and ICS in COPD patients at cardiovascular risk http://ow.ly/p6Is300ffoc.

Place, publisher, year, edition, pages
2016. Vol. 2, no 2, 00055-2016
National Category
Medical and Health Sciences
Identifiers
URN: urn:nbn:se:uu:diva-319046DOI: 10.1183/23120541.00055-2016PubMedID: 27730192OAI: oai:DiVA.org:uu-319046DiVA: diva2:1085936
Available from: 2017-03-30 Created: 2017-03-30 Last updated: 2017-03-30

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed
By organisation
Respiratory Medicine and Allergology
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar

Altmetric score

Total: 140 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf